18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis.

about

18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis.

Item

http://www.wikidata.org/entity/Q41428960

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

18F-fluorodeoxyglucose positro ...... gnosis of hepatic amyloidosis.

@en

type

Item

label

18F-fluorodeoxyglucose positro ...... gnosis of hepatic amyloidosis.

@en

prefLabel

18F-fluorodeoxyglucose positro ...... gnosis of hepatic amyloidosis.

@en

P1476

18F-fluorodeoxyglucose positro ...... gnosis of hepatic amyloidosis.

@en

P2093

Akinobu Tawada

http://www.w3.org/2001/XMLSchema#string

Fumio Imazeki

http://www.w3.org/2001/XMLSchema#string

Osamu Yokosuka

http://www.w3.org/2001/XMLSchema#string

Takashi Oide

http://www.w3.org/2001/XMLSchema#string

Tatsuo Kanda

http://www.w3.org/2001/XMLSchema#string

Toshio Tsuyuguchi

http://www.w3.org/2001/XMLSchema#string

Yukio Nakatani

http://www.w3.org/2001/XMLSchema#string

P2860

Gastrointestinal Manifestations of Amyloidosis

Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.

The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis.

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy.

Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation.

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

Primary amyloidosis and severe intrahepatic cholestatic jaundice.

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone.

18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma

P304

103-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.2147/IMCRJ.S63296

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25018655

http://www.w3.org/2001/XMLSchema#string

P932

4074181

http://www.w3.org/2001/XMLSchema#string